Healthy Clinical Trial
Official title:
Evaluation of the Effectiveness and Clinical Utility of Brain Network Activation (BNA™) Technology in the Management of Sport Related Concussion in Youth Athletes
Currently, there is no direct, reliable, bed-side, and non-invasive method for assessing
changes in brain activity associated with concussion. Event Related Potentials (ERPs), which
are temporal reflections of the neural mass electrical activity of cells in specific regions
of the brain that occur in response to stimuli, may offer such a method, as they provide
both a noninvasive and portable measure of brain function. The ERPs provide excellent
temporal information, but spatial resolution for ERPs has traditionally been limited.
However, by using high-density electroencephalograph (EEG) recording spatial resolution for
ERPs is improved significantly. The paradigm for the current study will combine
neurophysiological knowledge with mathematical signal processing and pattern recognition
methods (BNA™) to temporally and spatially map brain function, connectivity and
synchronization.
The proposed study will provide additional evidence for the utility and contribution of the
BNA™ test (reflecting temporal and spatial changes in brain activity as well as brain
functional connectivity associated with concussion) in concussion management.
The BNA test is basically divided to 3 phases - first EEG data is collected from subjects
using an EEG system while the subject is performing a cognitive task in front of a computer.
The EEG data is then analyzed using the advanced BNA™ technology. Finally, a report of the
BNA™ test is generated.
A single center study evaluating the effectiveness of BNA technology as an objective tool
for sport related concussion management in youth athletes' populations.
The study will include 150 athletes from Minnesota Youth Hockey Programs. Subjects enrolled
in this study will undergo a screening and baseline pre season visit and follow up visit/s.
1. Follow-up testing for concussed athletes - Concussed athletes will complete a series of
post concussion follow up visits. Each will consist of BNA™ test, ImPACT™ test, and
exam by neurologist or neurology nurse practitioner. The first visit will be within 72
hours of injury and re-evaluations will occur weekly until BNA has normalized AND
subject is asymptomatic. Subject may return to play at that point and subject will have
a final additional BNA™ test one week after the athlete returns to full activity. If
participant is still symptomatic and/or BNA is still abnormal at 6 weeks reevaluations
go to every 2 weeks for up to three months or clearing of symptoms AND normal BNA™. If
not back to baseline at three months, monthly reevaluations until study completion.
2. Follow up visit for non-concussed athletes - non-concussed athletes will complete a
follow up visit upon completion of the sport season.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |